#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma recurrent Allogenic stem cell transplantation Porphyria non-acute Alexander disease Autoimmune demyelinating disease Spina bifida Phaeochromocytoma Inflammatory myofibroblastic tumour Renal disorder Medullary thyroid cancer Angiosarcoma metastatic Pleomorphic leiomyosarcoma Choroidal dystrophy Vulval cancer recurrent Alveolar rhabdomyosarcoma More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Trials in Disease Adrenogenital syndrome – Diagnostics Rett syndrome – Basic Information Vascular malformation Synovial sarcoma metastatic Langerhans’ cell histiocytosis – Trials in Disease Angiosarcoma metastatic Lymphangioma – Treatment Waldenstrom’s macroglobulinaemia refractory – Life with Disease Mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tin816 Avalotcagene Ontaparvovec Zopiclone Hydroxi-Methionine Calcium Sodium Zirconium Cyclosilicate Doxazosin Mesilate Mepolizumab Vancomycin Caffeine Itacitinib Pacritinib Adenosine Dimeticone RUBIDIUM CHLORIDE Lib-01 Monohydrate Ramipril Emraclidine Cefuroxime Axetil Disodium Folinate Eight Treg More therapies…

    Learn about Your Condition

    Chronic disease Oedema Androgenetic alopecia Anal cancer recurrent Malformation venous Pouchitis K-ras gene mutation Breast proliferative changes Adenomyosis Angina pectoris Osteonecrosis of jaw Essential hypertension Candida infection Malignant melanoma stage II Arginase deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure

  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Chronic left ventricular failure
    • Left ventricular failure
    Belgium

  • Study on COR-1167 for Patients with Worsening Heart Failure

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Czechia Hungary Poland Romania Spain

  • Study on the Effects of Dobutamine and Levosimendan in Patients with Heart Failure and Reduced Left Ventricular Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Left ventricular failure
    • Cardiac failure
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Levosimendan
    Spain

  • A Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoxia
    • Pulmonary hypertension
    • Cardiac failure
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Preventing Heart Failure in Early Breast Cancer Patients Receiving Anthracycline Therapy with Sacubitril and Valsartan (LCZ696)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    • Breast cancer female
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Norway

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!